Search Results - "Isao ASAKAWA"

Low‐dose‐rate brachytherapy for prostate cancer: A 15‐year experience in Japan by Tanaka, Nobumichi, Asakawa, Isao, Hasegawa, Masatoshi, Fujimoto, Kiyohide

“…The history of prostate brachytherapy has passed one century. In 1983, modern low‐dose‐rate prostate brachytherapy using a transrectal ultrasound‐guided…”
Get full text

Comparative effectiveness of low-dose-rate brachytherapy with or without external beam radiotherapy in favorable and unfavorable intermediate-risk prostate cancer by Tsumura, Hideyasu, Tanaka, Nobumichi, Oguchi, Tomohiko, Owari, Takuya, Nakai, Yasushi, Asakawa, Isao, Iijima, Kazuyoshi, Kato, Haruaki, Hashida, Iwao, Tabata, Ken-ichi, Satoh, Takefumi, Ishiyama, Hiromichi

“…We compared clinical outcomes associated with seed brachytherapy (SEED-BT) alone and SEED-BT plus external-beam radiotherapy (EBRT) for intermediate-risk…”
Get full text

Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low‐dose‐rate brachytherapy by Tanaka, Nobumichi, Nakai, Yasushi, Asakawa, Isao, Yamaki, Kaori, Miyake, Makito, Hori, Shunta, Owari, Takuya, Fujii, Tomomi, Fujimoto, Kiyohide

“…Objectives To evaluate prognostic factors of biochemical recurrence (BCR) in each risk group of prostate cancer patients who underwent low‐dose‐rate…”
Get full text

Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer by Tanaka, Nobumichi, Asakawa, Isao, Nakai, Yasushi, Miyake, Makito, Anai, Satoshi, Fujii, Tomomi, Hasegawa, Masatoshi, Konishi, Noboru, Fujimoto, Kiyohide

“…To compare the PSA value at the last follow-up of patients who underwent prostate low-dose rate brachytherapy (LDR-BT) with that of patients who underwent…”
Get full text

Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer by Tsumura, Hideyasu, Tanaka, Nobumichi, Oguchi, Tomohiko, Owari, Takuya, Nakai, Yasushi, Asakawa, Isao, Iijima, Kazuyoshi, Kato, Haruaki, Hashida, Iwao, Tabata, Ken-Ichi, Satoh, Takefumi, Ishiyama, Hiromichi

“…We compared the oncological outcomes of patients who received seed brachytherapy (SEED-BT) with those who received radical prostatectomy (RP) for…”
Get full text

Coverage of the external prostatic region by the hybrid method compared with the conventional method of prostate low‐dose‐rate brachytherapy: A randomized controlled study by Tanaka, Nobumichi, Asakawa, Isao, Nakai, Yasushi, Miyake, Makito, Anai, Satoshi, Yamaki, Kaori, Fujii, Tomomi, Hasegawa, Masatoshi, Fujimoto, Kiyohide

“…Objectives To compare the dose evaluation parameters between conventional (using loose seed alone) and hybrid (using loose seeds in combination with stranded…”
Get full text

Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil by Maesaka, Fumisato, Tanaka, Nobumichi, Nakai, Yasushi, Asakawa, Isao, Tomizawa, Mitsuru, Owari, Takuya, Miyake, Makito, Anai, Satoshi, Yamaki, Kaori, Fujii, Tomomi, Hasegawa, Masatoshi, Fujimoto, Kiyohide

“…Objectives To compare the effects of naftopidil and silodosin administration on the quality of life of patients with prostate cancer who underwent…”
Get full text

Biochemical control of the combination of cyclooxygenase‐2 inhibitor and 125I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial by Nakai, Yasushi, Tanaka, Nobumichi, Asakawa, Isao, Anai, Satoshi, Miyake, Makito, Morizawa, Yosuke, Hori, Shunta, Owari, Takuya, Fujii, Tomomi, Ohbayashi, Chiho, Yamaki, Kaori, Hasegawa, Masatoshi, Fujimoto, Kiyohide

“…Objectives To evaluate the use of cyclooxygenase‐2 inhibitors in patients receiving low‐dose‐rate brachytherapy for prostate cancer. Methods A total of 310…”
Get full text

Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone by Nakai, Yasushi, Tanaka, Nobumichi, Asakawa, Isao, Anai, Satoshi, Miyake, Makito, Morizawa, Yosuke, Hori, Shunta, Owari, Takuya, Fujii, Tomomi, Yamaki, Kaori, Hasegawa, Masatoshi, Fujimoto, Kiyohide

“…Abstract Background Because patients with prostate-specific antigen (PSA) bounce do not experience biochemical recurrence (BCR) until PSA bounce occurs, the…”
Get full text

Urethral toxicity after LDR brachytherapy: Experience in Japan by Tanaka, Nobumichi, Asakawa, Isao, Hasegawa, Masatoshi, Fujimoto, Kiyohide

“…Abstract Urinary toxicity is common after low-dose-rate (LDR) brachytherapy, and the resolution of urinary toxicity is a concern. In particular, urinary…”
Get full text

Income and Employment of Patients at the Start of and During Follow-up After Palliative Radiation Therapy for Bone Metastasis by Shirato, Hiroki, Harada, Hideyuki, Iwasaki, Yukako, Notsu, Akifumi, Yamada, Kazunari, Uezono, Haruka, Koide, Yutaro, Wada, Hitoshi, Kubota, Hikaru, Shikama, Naoto, Yamazaki, Takuya, Ito, Kei, Heianna, Joichi, Okada, Yukinori, Tonari, Ayako, Takahashi, Shigeo, Kosugi, Takashi, Ejima, Yasuo, Katoh, Norio, Yoshida, Kayo, Komiyama, Takafumi, Uchida, Nobue, Miwa, Misako, Watanabe, Miho, Nagakura, Hisayasu, Saito, Tetsuo, Ikeda, Hiroko, Asakawa, Isao, Seiichiro, Tateishi, Takahashi, Takeo, Shigematsu, Naoyuki

“…The aim of this study was to understand the income and employment status of patients at the start of and during follow-up after palliative radiation therapy…”
Get full text

Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy by Tanaka, Nobumichi, Asakawa, Isao, Anai, Satoshi, Hirayama, Akihide, Hasegawa, Masatoshi, Konishi, Noboru, Fujimoto, Kiyohide

“…To compare the periodical incidence rates of genitourinary (GU) and gastrointestinal (GI) toxicity in patients who underwent prostate low-dose-rate…”
Get full text

The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions by Tanaka, Nobumichi, Asakawa, Isao, Katayama, Emiko, Hirayama, Akihide, Hasegawa, Masatoshi, Konishi, Noboru, Fujimoto, Kiyohide

“…To assess the biochemical recurrence (BCR)-free rate in patients who underwent prostate low-dose-rate brachytherapy (LDR-brachytherapy), using two different…”
Get full text

Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer by Miyake, Makito, Tanaka, Nobumichi, Asakawa, Isao, Tatsumi, Yoshihiro, Nakai, Yasushi, Anai, Satoshi, Torimoto, Kazumasa, Aoki, Katsuya, Yoneda, Tatsuo, Hasegawa, Masatoshi, Konishi, Noboru, Fujimoto, Kiyohide

“…Abstract Background and purpose The aim of this study was to evaluate chronologic changes in lower urinary tract symptoms (LUTS), health-related (HR) quality…”
Get full text

Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute by Miyake, Makito, Tanaka, Nobumichi, Asakawa, Isao, Hori, Shunta, Morizawa, Yosuke, Tatsumi, Yoshihiro, Nakai, Yasushi, Inoue, Takeshi, Anai, Satoshi, Torimoto, Kazumasa, Aoki, Katsuya, Hasegawa, Masatoshi, Fujii, Tomomi, Konishi, Noboru, Fujimoto, Kiyohide

“…The aim of this study was to evaluate the combined use of the overactive bladder symptom score (OABSS) and International Prostate Symptom Score (IPSS) as an…”
Get full text

Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil by Tanaka, Nobumichi, Torimoto, Kazumasa, Asakawa, Isao, Miyake, Makito, Anai, Satoshi, Hirayama, Akihide, Hasegawa, Masatoshi, Konishi, Noboru, Fujimoto, Kiyohide

“…To evaluate the effect of two different alpha-1 adrenoceptor antagonists on lower urinary tract symptoms in patients who underwent LDR-brachytherapy. A total…”
Get full text

Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy by Kawaguchi, Ryuji, Furukawa, Naoto, Kobayashi, Hiroshi, Asakawa, Isao

“…The aim of the present study was to assess prognostic factors for patients with locally advanced cervical cancer treated with radiotherapy as the primary…”
Get full text

Quality of life in patients who underwent 125I brachytherapy, 125I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer by Nakai, Yasushi, Tanaka, Nobumichi, Asakawa, Isao, Anai, Satoshi, Miyake, Makito, Hori, Shunta, Morizawa, Yosuke, Tatsumi, Yoshihiro, Hasegawa, Masatoshi, Fujii, Tomomi, Fujimoto, Kiyohide

“…Abstract The purpose of this study was to evaluate quality of life (QOL) in prostate cancer patients treated with 125I brachytherapy (BT), 125I brachytherapy…”
Get full text

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer by Onishi, Kenta, Tanaka, Nobumichi, Miyake, Makito, Nakai, Yasushi, Anai, Satoshi, Torimoto, Kazumasa, Yamaki, Kaori, Asakawa, Isao, Hasegawa, Masatoshi, Fujii, Tomomi, Konishi, Noboru, Fujimoto, Kiyohide

“…•Patients who received BT experienced acute urinary morbidity 3 months after BT of the prostate.•Acute urinary symptoms gradually improved with time and…”
Get full text

The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions by Miyake, Makito, Tanaka, Nobumichi, Asakawa, Isao, Owari, Takuya, Hori, Shunta, Morizawa, Yosuke, Nakai, Yasushi, Inoue, Takeshi, Anai, Satoshi, Torimoto, Kazumasa, Hasegawa, Masatoshi, Fujii, Tomomi, Konishi, Noboru, Fujimoto, Kiyohide

“…The clinical management and follow-up of patients with recurrent prostate cancer after salvage radiotherapy (SRT) has not yet been established, and no…”
Get full text